Detalhe da pesquisa
1.
Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.
Carcinogenesis
; 36 Suppl 1: S2-18, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26106139
2.
The Tumor Suppressor Kinase LKB1: Metabolic Nexus.
Front Cell Dev Biol
; 10: 881297, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35573694
3.
Single-Cell RNA Sequencing Analysis Using Fluidigm C1 Platform for Characterization of Heterogeneous Transcriptomes.
Methods Mol Biol
; 2508: 261-278, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737246
4.
Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer.
Cancers (Basel)
; 13(12)2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208071
5.
Single-cell RNA sequencing for the identification of early-stage lung cancer biomarkers from circulating blood.
NPJ Genom Med
; 6(1): 87, 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34654834
6.
S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample Analysis.
Cancers (Basel)
; 12(12)2020 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33297495
7.
LKB1 catalytically deficient mutants enhance cyclin D1 expression.
Cancer Res
; 67(12): 5622-7, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17575127
8.
Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.
Front Immunol
; 9: 1894, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30158936
9.
Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)â.
Cell Death Dis
; 9(9): 920, 2018 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206209
10.
Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.
Mol Cell Biol
; 22(17): 6247-60, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12167717
11.
Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.
Oncoimmunology
; 5(7): e1151591, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622015
12.
Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss.
Oncotarget
; 5(24): 12738-52, 2014 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25436981
13.
Omega-3 polyunsaturated fatty acid promotes the inhibition of glycolytic enzymes and mTOR signaling by regulating the tumor suppressor LKB1.
Cancer Biol Ther
; 14(11): 1050-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24025358
14.
Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways.
PLoS One
; 8(2): e56567, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23451056
15.
LKB1 catalytic activity contributes to estrogen receptor alpha signaling.
Mol Biol Cell
; 20(11): 2785-95, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19369417
16.
Triptolide: An inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells.
Cancer Biol Ther
; 8(21): 2054-62, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19783906